Free Trial

Strata Critical Medical (SRTA) Competitors

$6.13 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$6.11 -0.02 (-0.31%)
As of 05/22/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SRTA vs. FLNG, GSL, NVGS, CCEC, and VTOL

Should you buy Strata Critical Medical stock or one of its competitors? MarketBeat compares Strata Critical Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Strata Critical Medical include Flex LNG (FLNG), Global Ship Lease (GSL), Navigator (NVGS), Capital Clean Energy Carriers (CCEC), and Bristow Group (VTOL). These companies are all part of the "transportation" industry.

How does Strata Critical Medical compare to Flex LNG?

Strata Critical Medical (NASDAQ:SRTA) and Flex LNG (NYSE:FLNG) are both small-cap transportation companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

47.4% of Strata Critical Medical shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Comparatively, 0.3% of Flex LNG shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Strata Critical Medical currently has a consensus price target of $8.00, indicating a potential upside of 30.51%. Flex LNG has a consensus price target of $24.00, indicating a potential downside of 24.74%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Strata Critical Medical is more favorable than Flex LNG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Flex LNG
2 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Flex LNG has a net margin of 22.26% compared to Strata Critical Medical's net margin of 20.56%. Flex LNG's return on equity of 12.15% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Flex LNG 22.26%12.15%3.37%

In the previous week, Strata Critical Medical had 1 more articles in the media than Flex LNG. MarketBeat recorded 2 mentions for Strata Critical Medical and 1 mentions for Flex LNG. Flex LNG's average media sentiment score of 0.00 beat Strata Critical Medical's score of -0.64 indicating that Flex LNG is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Negative
Flex LNG
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Strata Critical Medical has a beta of 2.15, indicating that its share price is 115% more volatile than the broader market. Comparatively, Flex LNG has a beta of 0.2, indicating that its share price is 80% less volatile than the broader market.

Flex LNG has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Flex LNG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$197.14M2.69$41.35M-$0.08N/A
Flex LNG$347.64M4.96$74.82M$1.4022.78

Summary

Flex LNG beats Strata Critical Medical on 9 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Global Ship Lease?

Global Ship Lease (NYSE:GSL) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Global Ship Lease has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.15, indicating that its stock price is 115% more volatile than the broader market.

50.1% of Global Ship Lease shares are owned by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are owned by institutional investors. 7.4% of Global Ship Lease shares are owned by company insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Global Ship Lease currently has a consensus target price of $46.50, suggesting a potential upside of 22.57%. Strata Critical Medical has a consensus target price of $8.00, suggesting a potential upside of 30.51%. Given Strata Critical Medical's higher possible upside, analysts clearly believe Strata Critical Medical is more favorable than Global Ship Lease.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Ship Lease
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

Global Ship Lease has a net margin of 54.33% compared to Strata Critical Medical's net margin of 20.56%. Global Ship Lease's return on equity of 22.35% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Ship Lease54.33% 22.35% 13.99%
Strata Critical Medical 20.56%-4.06%-3.49%

In the previous week, Global Ship Lease had 10 more articles in the media than Strata Critical Medical. MarketBeat recorded 12 mentions for Global Ship Lease and 2 mentions for Strata Critical Medical. Global Ship Lease's average media sentiment score of 0.30 beat Strata Critical Medical's score of -0.64 indicating that Global Ship Lease is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Ship Lease
1 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Negative

Global Ship Lease has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Global Ship Lease, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Ship Lease$766.45M1.78$416.45M$10.533.60
Strata Critical Medical$197.14M2.69$41.35M-$0.08N/A

Summary

Global Ship Lease beats Strata Critical Medical on 12 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Navigator?

Strata Critical Medical (NASDAQ:SRTA) and Navigator (NYSE:NVGS) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 19.0% of Navigator shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 0.4% of Navigator shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Navigator has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Navigator, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$197.14M2.69$41.35M-$0.08N/A
Navigator$586.96M2.43$100.12M$1.6314.17

Strata Critical Medical currently has a consensus price target of $8.00, suggesting a potential upside of 30.51%. Navigator has a consensus price target of $23.33, suggesting a potential upside of 1.01%. Given Strata Critical Medical's higher possible upside, equities analysts clearly believe Strata Critical Medical is more favorable than Navigator.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Navigator
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, Navigator had 2 more articles in the media than Strata Critical Medical. MarketBeat recorded 4 mentions for Navigator and 2 mentions for Strata Critical Medical. Navigator's average media sentiment score of 0.14 beat Strata Critical Medical's score of -0.64 indicating that Navigator is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Negative
Navigator
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Strata Critical Medical has a net margin of 20.56% compared to Navigator's net margin of 18.84%. Navigator's return on equity of 7.01% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Navigator 18.84%7.01%3.80%

Strata Critical Medical has a beta of 2.15, meaning that its stock price is 115% more volatile than the broader market. Comparatively, Navigator has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

Summary

Navigator beats Strata Critical Medical on 10 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Capital Clean Energy Carriers?

Capital Clean Energy Carriers (NASDAQ:CCEC) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

47.4% of Strata Critical Medical shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Strata Critical Medical had 1 more articles in the media than Capital Clean Energy Carriers. MarketBeat recorded 2 mentions for Strata Critical Medical and 1 mentions for Capital Clean Energy Carriers. Capital Clean Energy Carriers' average media sentiment score of 1.30 beat Strata Critical Medical's score of -0.64 indicating that Capital Clean Energy Carriers is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Capital Clean Energy Carriers
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Negative

Capital Clean Energy Carriers presently has a consensus price target of $24.75, indicating a potential upside of 10.94%. Strata Critical Medical has a consensus price target of $8.00, indicating a potential upside of 30.51%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, analysts clearly believe Strata Critical Medical is more favorable than Capital Clean Energy Carriers.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Capital Clean Energy Carriers
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

Capital Clean Energy Carriers has a net margin of 28.02% compared to Strata Critical Medical's net margin of 20.56%. Capital Clean Energy Carriers' return on equity of 6.73% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Capital Clean Energy Carriers28.02% 6.73% 2.39%
Strata Critical Medical 20.56%-4.06%-3.49%

Capital Clean Energy Carriers has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Capital Clean Energy Carriers, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Capital Clean Energy Carriers$392.71M3.32$170.76M$1.8911.80
Strata Critical Medical$197.14M2.69$41.35M-$0.08N/A

Capital Clean Energy Carriers has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.15, indicating that its stock price is 115% more volatile than the broader market.

Summary

Capital Clean Energy Carriers beats Strata Critical Medical on 10 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Bristow Group?

Strata Critical Medical (NASDAQ:SRTA) and Bristow Group (NYSE:VTOL) are both small-cap transportation companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

Bristow Group has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Bristow Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$197.14M2.69$41.35M-$0.08N/A
Bristow Group$1.49B0.85$129.07M$3.8411.13

Strata Critical Medical has a net margin of 20.56% compared to Bristow Group's net margin of 7.51%. Bristow Group's return on equity of 11.10% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Bristow Group 7.51%11.10%4.95%

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 93.3% of Bristow Group shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 13.4% of Bristow Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Strata Critical Medical currently has a consensus price target of $8.00, suggesting a potential upside of 30.51%. Bristow Group has a consensus price target of $60.00, suggesting a potential upside of 40.44%. Given Bristow Group's higher possible upside, analysts clearly believe Bristow Group is more favorable than Strata Critical Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Bristow Group
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Strata Critical Medical has a beta of 2.15, indicating that its share price is 115% more volatile than the broader market. Comparatively, Bristow Group has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market.

In the previous week, Strata Critical Medical had 1 more articles in the media than Bristow Group. MarketBeat recorded 2 mentions for Strata Critical Medical and 1 mentions for Bristow Group. Bristow Group's average media sentiment score of 0.00 beat Strata Critical Medical's score of -0.64 indicating that Bristow Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Negative
Bristow Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Bristow Group beats Strata Critical Medical on 10 of the 17 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTA vs. The Competition

MetricStrata Critical MedicalAir Transportation IndustryTransportation, Communications, Electric, Gas, And Sanitary SectorNASDAQ Exchange
Market Cap$530.41M$1.01B$7.19B$12.34B
Dividend YieldN/AN/A6.19%5.28%
P/E Ratio-76.639.7919.9425.65
Price / Sales2.691.5531.3986.31
Price / CashN/A2.1212.1556.67
Price / Book1.861.861.007.14
Net Income$41.35M$196.61M$286.45M$335.98M
7 Day Performance17.43%19.40%21.78%4.15%
1 Month Performance24.59%17.78%17.92%2.54%
1 Year PerformanceN/AN/AN/A35.06%

Strata Critical Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRTA
Strata Critical Medical
2.1117 of 5 stars
$6.13
flat
$8.00
+30.5%
N/A$530.41M$197.14MN/A130
FLNG
Flex LNG
0.6413 of 5 stars
$32.74
+0.5%
$24.00
-26.7%
+39.3%$1.77B$347.64M23.368
GSL
Global Ship Lease
4.9461 of 5 stars
$41.36
+2.6%
$40.33
-2.5%
+55.1%$1.48B$766.45M3.637
NVGS
Navigator
3.3345 of 5 stars
$23.91
+0.0%
$23.33
-2.4%
+65.1%$1.47B$576.17M14.65120
CCEC
Capital Clean Energy Carriers
4.7152 of 5 stars
$21.88
+4.6%
$24.75
+13.1%
-3.7%$1.28B$392.71M11.58N/A

Related Companies and Tools


This page (NASDAQ:SRTA) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners